Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease.

Abstract

Presymptomatic FAD individuals show widespread MRglc reductions consistent with the typical AD PET pattern in the relative absence of structural brain atrophy. These data further suggest that PET MRglc measures may serve as biomarkers for the preclinical diagnosis of AD.